Table 2.

Treatment given for SARS-CoV-2 infection and AKI

Patient No.Need for RRTSteroid Use/IndicationCOVID-19–Specific TreatmentKidney Disease–Specific Treatment
1YesYes/COVID-19HydroxychloroquineNone
2YesYes/COVID-19HydroxychloroquineNone
Azithromycin
3YesYes/COVID-19HydroxychloroquineNone
Anakinra
Convalescent plasma
4YesYes/COVID-19HydroxychloroquineNone
Anakinra
Convalescent plasma
5NoNoNoneNone
6YesYes/autoimmune hemolytic anemiaNoneRituximab (for gemcitabine-induced TMA)
7YesYes/COVID-19HydroxychloroquineEculizumab
Tocilizumab
Steroids
Convalescent plasma
8YesYes/vasculitisHydroxychloroquineIntravenous methylprednisolone daily for three days
Tocilizumab
Convalescent plasma
9NoNoNoneNone
10Yes (at an outside hospital)Yes/acute goutNoneNone